Lupin Pharma is planning a cancer drug manufacturing facility at its Mihan plant. It hopes to start commercial production from June 2016 onwards. Estimated cost of the project is around Rs.190 crores. The company has also plans to develop a facility for making an anti-cancer injection along with it. However, the commercial production of anti-cancer drugs may take 3-4 years.
Extracted from TOI, May 25,’15